These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds. Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886 [TBL] [Abstract][Full Text] [Related]
8. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential. Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives. Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore. Abdellatif KR; Fadaly WA Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies. Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325 [TBL] [Abstract][Full Text] [Related]
14. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621 [TBL] [Abstract][Full Text] [Related]
15. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study. El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study. Abdel-Aziz AA; ElTahir KE; Asiri YA Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586 [TBL] [Abstract][Full Text] [Related]
19. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study. Sakr A; Kothayer H; Ibrahim SM; Baraka MM; Rezq S Bioorg Chem; 2019 Mar; 84():76-86. PubMed ID: 30481648 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile. Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]